Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-11
SponsorKanuni Sultan Suleyman Training and Research Hospital
About this trial
This prospective observational study aims to evaluate the association between daily screen exposure duration and postoperative emergence delirium in children aged 2 to 11 years undergoing elective lower abdominal surgery. Daily screen time will be assessed using a parent-reported questionnaire administered preoperatively. Postoperative emergence delirium will be evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scale at 5, 10, 15, and 30 minutes after surgery.
The primary outcome is the association between daily screen time and PAED score within the first 30 minutes postoperatively. Secondary outcomes include the associations between PAED score and age at first screen exposure, type of viewed content, parental screen use, passive screen exposure, and the presence of a screen in the child's bedroom. The study is designed to improve understanding of whether screen-related environmental factors are associated with postoperative behavioral recovery in pediatric surgical patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children aged 2 to 11 years
Scheduled for elective lower abdominal surgery
Planned procedures include inguinal hernia repair, orchiopexy for undescended testis, or circumcision
American Society of Anesthesiologists (ASA) physical status I-II
Disqualifiers
Planned or administered premedication before surgery
Emergency surgery
Reoperation
Developmental delay, neurodevelopmental disorder, or known psychiatric disease
Trial population
The study population consists of children aged 2-11 years undergoing elective lower abdominal surgery, including inguinal hernia repair, orchiopexy for undescended testis, and circumcision, at a tertiary care hospital. Participants are classified according to daily screen exposure duration based on parent-reported data. Only patients meeting the inclusion criteria and whose parents provide written informed consent will be enrolled. Children with developmental, neurological, or psychiatric disorders, or those receiving premedication, will be excluded to ensure reliable behavioral assessment using the PAED scale.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Daily Screen Exposure Duration
Diagnostic testThis is a non-interventional observational study. The exposure of interest is the daily screen time duration of children aged 2-11 years, as reported by parents. Participants are categorized into two groups based on screen exposure (\<2 hours/day and \>2 hours/day). No active intervention is applied.
Treatment groups
288 Participants
are divided into 2 treatment groupsGroup A: Low Screen Exposure (<2 Hours/Day)1 intervention
Group B: High Screen Exposure (>2 Hours/Day)1 intervention
Trial outcomes
Primary outcomes
1
Association Between Daily Screen Time and PAED Score
Correlation between daily screen exposure duration (continuous variable) and PAED score.
Time frame
Within the first 30 minutes after emergence from anesthesiaSecondary outcomes
1
Age at First Screen Exposure and Emergence Delirium
Association between age at first screen exposure and PAED score.
Time frame
Within the first 30 minutes postoperatively2
Influence of Sociodemographic Factors on Emergence Delirium
Assessment of the effect of age, sex, parental education level, and family structure on PAED scores.
Time frame
Within the first 30 minutes postoperatively3
Type of Screen Content and Emergence Delirium
Evaluation of the relationship between type of content viewed (cartoons, games, educational, mixed) and PAED score.
Time frame
Within the first 30 minutes postoperatively4
Parental Screen Use and Emergence Delirium
Association between parental daily screen use and PAED score.
Time frame
Within the first 30 minutes postoperativelySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov